A cancer specialist has delved into the key red flags of malignant moles - and a common myth of what's normal.

As Dr Wilson explains, malignant moles can indeed be pale ... Spokespeople at the US-based City of Hope Cancer Centre explain ...

In a complete response letter, the FDA indicates the drug trial is not an adequate, well-controlled clinical investigation, ...

Discover a study exploring cutting-edge melanoma vaccines and their potential to enhance long-term survival in high-risk patients.

Melanoma testing could one day be done at home with a skin patch and test strip with two lines, similar to COVID-19 home ...

The FDA has issued a CRL to Replimmune regarding the BLA for vusolimogene oderparepvec (RP1) in combination with nivolumab for advanced melanoma.

Adding SCIB1 or iSCIB1+ to standard treatments helped more patients with advanced melanoma respond and live longer without ...

IO Biotech’s off-the-shelf cancer vaccine shows promise in melanoma with key data ahead, but funding risk limits near-term ...

Choroidal malignant melanoma is a common intraocular malignancy. The traditional standard treatment is enucleation, i.e. eye removal. Although enucleation can effectively control the local lesion ...

The FDA cited trial design concerns and lack of substantial evidence in denying approval for Replimune’s biologics license application in advanced melanoma.